Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Maria J H de Hair"'
Autor:
Ivy Y Choi, Olga N Karpus, Jason D Turner, Debbie Hardie, Jennifer L Marshall, Maria J H de Hair, Karen I Maijer, Paul P Tak, Karim Raza, Jörg Hamann, Christopher D Buckley, Danielle M Gerlag, Andrew Filer
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0182751 (2017)
Previous studies have shown increased expression of stromal markers in synovial tissue (ST) of patients with established rheumatoid arthritis (RA). Here, ST expression of stromal markers in early arthritis in relationship to diagnosis and prognostic
Externí odkaz:
https://doaj.org/article/890b055de3ca40f586d0a6584e8bd9e6
Autor:
Maria J H de Hair, Patrick Leclerc, Elize C Newsum, Karen I Maijer, Marleen G H van de Sande, Tamara H Ramwadhdoebe, Dirkjan van Schaardenburg, Lisa G M van Baarsen, Marina Korotkova, Danielle M Gerlag, Paul-Peter Tak, Per-Johan Jakobsson
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0133669 (2015)
Arthralgia may precede the development of synovial inflammation in autoantibody-positive individuals at risk of developing rheumatoid arthritis (RA). A major pathway involved in pain is the prostaglandin (PG) E2 pathway. We investigated this pathway
Externí odkaz:
https://doaj.org/article/e356b88270344edea624e999999c26e9
Autor:
Karen I Maijer, Elena Neumann, Ulf Müller-Ladner, Daniël A C A D Drop, Tamara H Ramwadhdoebe, Ivy Y K Choi, Daniëlle M Gerlag, Maria J H de Hair, Paul P Tak
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0144932 (2015)
We have previously shown that overweight may increase the risk of developing rheumatoid arthritis (RA) in autoantibody positive individuals. Adipose tissue could contribute to the development of RA by production of various bioactive peptides. Therefo
Externí odkaz:
https://doaj.org/article/1bf81916a31141378485f7d8dec2ce0e
Autor:
Marleen G H van de Sande, Maria J H de Hair, Yvonne Schuller, Gijs P M van de Sande, Carla A Wijbrandts, Huib J Dinant, Danielle M Gerlag, Paul P Tak
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e36668 (2012)
OBJECTIVES: It has been shown in early arthritis cohorts that the 2010 ACR/EULAR criteria for rheumatoid arthritis (RA) enable an earlier diagnosis, perhaps at the cost of a somewhat more heterogeneous patient population. We describe the features of
Externí odkaz:
https://doaj.org/article/27094cbb3b5f45d99e6c75cd178ace88
Autor:
Monika Hansson, Paul P. Tak, Matthijs Janssen, M. Starmans-Kool, Niek de Vries, Aeilko H. Zwinderman, Man Wai Tang, M Safy, KI Maijer, Danielle M. Gerlag, Sander W. Tas, Maria J. H. de Hair, Astrid van Tubergen
Publikováno v:
Annals of the Rheumatic Diseases, 78(2), 179-185. BMJ Publishing Group
Annals of the Rheumatic Diseases
Annals of the rheumatic diseases, 78(2), 179-185. BMJ Publishing Group
Annals of the Rheumatic Diseases
Annals of the rheumatic diseases, 78(2), 179-185. BMJ Publishing Group
ObjectivesWe explored the effects of B-cell directed therapy in subjects at risk of developing autoantibodypositive rheumatoid arthritis (RA), who never experienced inflammatory arthritis before, and explored biomarkers predictive of arthritis develo
Autor:
Paco M J Welsing, Johannes W G Jacobs, Jacob M van Laar, Matthijs S. van der Leeuw, Reinhard Bos, Faouzia Fodili, Anne C. A. Marijnissen, Suzanne P. Linn-Rasker, Janneke Tekstra, Maria J. H. de Hair
Publikováno v:
Trials
Trials, Vol 21, Iss 1, Pp 1-11 (2020)
Trials, Vol 21, Iss 1, Pp 1-11 (2020)
Background Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease, predominantly affecting joints, which is initially treated with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs). In RA patients with insufficie
Autor:
Athina Spiliopoulou, Paul M. McKeigue, Peter Orchard, Costantino Pitzalis, Suzanne M M Verstappen, John D. Isaacs, Richard M. Weinshilboum, Ronald F van Vollenhoven, Donna K. Arnett, Leonid Padyukov, John C. Taylor, Jackie L Nam, Jonathan Massey, Anne Barton, Jianmei Wang, Heather J. Cordell, Jennifer H. Barrett, Stella Aslibekyan, Ian C. Scott, Paul P. Tak, Marco Colombo, Iain B. McInnes, Borbala Mifsud, Darren Plant, Michael R. Barnes, Paul Emery, Michael D Morgan, Duncan Porter, Sarah Twigg, Jane E. Freeston, Michiaki Kubo, Tim Bongartz, Felix Agakov, Andrew P. Cope, Ann W. Morgan, Maria J. H. de Hair, Jenna L. Strathdee, S. Louis Bridges, Taisei Mushiroda
Publikováno v:
Taylor, J C, Bongartz, T, Massey, J, Mifsud, B, Spiliopoulou, A, Scott, I C, Wang, J, Morgan, M, Plant, D, Colombo, M, Orchard, P, Twigg, S, McInnes, I B, Porter, D, Freeston, J, Nam, J L, Cordell, H J, Issacs, J D, Strathdee, J L, Arnett, D, De Hair, M J H, Tak, P P, Aslibekyan, S, van Vollenhoven, R F, Padyukov, L, Bridges, S L, Pitzalis, C, Cope, A P, Verstappen, S, Emery, P, Barnes, M R, Agakov, F, McKeigue, P M, Mushiroda, T, Kubo, M, Weinshilboum, R M, Barton, A, Morgan, A W & Barrett, J H 2018, ' Genome-wide Association Study of Response to Methotrexate in Early Rheumatoid Arthritis Patients ', Pharmacogenomics Journal . https://doi.org/10.1038/s41397-018-0025-5
2018, ' Genome-wide Association Study of Response to Methotrexate in Early Rheumatoid Arthritis Patients ', Pharmacogenomics Journal . https://doi.org/10.1038/s41397-018-0025-5
2018, ' Genome-wide Association Study of Response to Methotrexate in Early Rheumatoid Arthritis Patients ', Pharmacogenomics Journal . https://doi.org/10.1038/s41397-018-0025-5
Methotrexate (MTX) monotherapy is a common first treatment for rheumatoid arthritis (RA), but many patients do not respond adequately. In order to identify genetic predictors of response, we have combined data from two consortia to carry out a genome
Autor:
Danielle M. Gerlag, Sander W. Tas, Paul P. Tak, Maria J. H. de Hair, KI Maijer, Christiaan van der Leij, Mario Maas, Cristina Lavini
Publikováno v:
Arthritis & Rheumatology. 68:587-596
Objective. Analysis of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) using pharmacokinetic modeling (PKM) provides quantitative measures that mirror microvessel integrity and can be used as an objective marker of the level of synovia
Publikováno v:
Clinical Reviews in Allergy & Immunology, 55(3), 312–331. Humana Press
Clinical Reviews in Allergy & Immunology
Clinical Reviews in Allergy & Immunology
Systemic sclerosis (SSc) is a highly heterogeneous disease caused by a complex molecular circuitry. For decades, clinical and molecular research focused on understanding the primary process of fibrosis. More recently, the inflammatory, immunological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5f9c53b67f910a371bc4fbc077b61b3
https://dspace.library.uu.nl/handle/1874/376958
https://dspace.library.uu.nl/handle/1874/376958
Autor:
C.C. Hwang, Jacob M van Laar, Floris P J G Lafeber, Mohsen Elshahaly, Xinyu Liu, Y K Onno Teng, Nadia M T Roodenrijs, Janneke Tekstra, Eric H. Sasso, Maria J. H. de Hair, Gill Wheater
Publikováno v:
Arthritis Research & Therapy
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-9 (2018)
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-9 (2018)
Background A multi-biomarker disease activity (MBDA) score has been validated as an objective measure of disease activity in rheumatoid arthritis (RA) and shown to track response to treatment with several disease-modifying anti-rheumatic drugs (DMARD